TD Cowen Trims Teladoc Health (NYSE:TDOC) Target Price to $15.00

Teladoc Health (NYSE:TDOC) had its price target decreased by TD Cowen from $16.00 to $15.00 in a research note issued to investors on Friday, Benzinga reports. TD Cowen currently has a hold rating on the health services provider’s stock.

Several other equities analysts have also commented on TDOC. Piper Sandler lowered their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an overweight rating for the company in a research report on Wednesday, February 21st. Truist Financial lowered their price objective on shares of Teladoc Health from $23.00 to $17.00 and set a hold rating for the company in a research report on Wednesday, March 6th. Cantor Fitzgerald assumed coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They set an overweight rating and a $22.00 price objective for the company. Royal Bank of Canada lowered their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an outperform rating for the company in a research report on Wednesday, February 21st. Finally, Barclays lowered their price objective on shares of Teladoc Health from $25.00 to $20.00 and set an overweight rating for the company in a research report on Friday. Eleven analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of Hold and a consensus price target of $19.00.

Teladoc Health Stock Performance

TDOC opened at $13.01 on Friday. The stock has a market capitalization of $2.20 billion, a price-to-earnings ratio of -9.23 and a beta of 0.94. The company has a fifty day moving average of $14.85 and a 200 day moving average of $17.71. Teladoc Health has a fifty-two week low of $12.65 and a fifty-two week high of $30.41. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. The company had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same period in the previous year, the business posted ($0.37) earnings per share. The business’s revenue was up 2.7% on a year-over-year basis. As a group, sell-side analysts forecast that Teladoc Health will post -1.06 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Arnnon Geshuri sold 7,500 shares of the firm’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the transaction, the insider now owns 38,470 shares of the company’s stock, valued at approximately $579,358.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, insider Arnnon Geshuri sold 7,500 shares of the firm’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the transaction, the insider now owns 38,470 shares of the company’s stock, valued at approximately $579,358.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Andrew Turitz sold 6,190 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The disclosure for this sale can be found here. Insiders have sold 135,441 shares of company stock valued at $2,038,251 in the last 90 days. Company insiders own 1.63% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Newbridge Financial Services Group Inc. increased its position in Teladoc Health by 2,130.9% during the 1st quarter. Newbridge Financial Services Group Inc. now owns 11,400 shares of the health services provider’s stock valued at $172,000 after purchasing an additional 10,889 shares during the period. Westside Investment Management Inc. increased its position in Teladoc Health by 37.7% during the 1st quarter. Westside Investment Management Inc. now owns 5,662 shares of the health services provider’s stock valued at $85,000 after purchasing an additional 1,550 shares during the period. Allspring Global Investments Holdings LLC increased its position in Teladoc Health by 74.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after purchasing an additional 8,750 shares during the period. Counterpoint Mutual Funds LLC purchased a new position in Teladoc Health during the 1st quarter valued at about $271,000. Finally, Ignite Planners LLC increased its position in Teladoc Health by 6.9% during the 1st quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider’s stock valued at $198,000 after purchasing an additional 857 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.